New survey indicates 84% of type 2 diabetes patients in UK would switch medication if it reduced pill burden

18 November 2009

A new survey of patients with type 2 diabetes shows that more than three-quarters of them are taking medication to control their diabetes. Of this group, 84% would consider switching medication if it meant taking fewer tablets. Yet nearly half had never had any changes made to their medication, even though 35% had been diagnosed with type 2 diabetes for between five and 10 years, and 13% for more than 10 years.

The on-line survey of 100 people with type 2 diabetes (carried out by TNS on behalf of the UK unit of Japan's leading drugmaker Takeda) also found that half of all respondents could not correctly define hypoglycaemia, while 49% who had suffered hypoglycemic-like symptoms had not reported them to their general practitioner or practice diabetic nurse. Indeed, 14% of respondents claimed never to have heard the term hypoglycemia.

There are currently over 2.5 million people with diabetes in the UK and in this survey, nearly 40% of patients took between four and more than nine tablets daily. As many as 41% of respondents stated they wished they could reduce the number of tablets they take daily. At least 16% of respondents were taking four tablets per day and 9% more than six. In addition, 24% had concerns over possible drug side effects.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical